Evidence map›Paper›PMID 28883476›Full record

ArticleScientific reports2017

Measurement of gut permeability using fluorescent tracer agent technology.

Richard B Dorshow, Carla Hall-Moore, Nurmohammad Shaikh, Michael R Talcott, William A Faubion, Thomas E Rogers, Jeng Jong Shieh, Martin P Debreczeny, James R Johnson, Roy B Dyer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Effects of Early Enteral Glutamine Supplementation on Intestinal Permeability in Critically Ill Patients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2019
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Richard B DorshowMediBeacon Inc, St. Louis, MO, USA.
Carla Hall-MooreDepartment of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Nurmohammad ShaikhDepartment of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Michael R TalcottDivision of Comparative Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
William A FaubionDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Thomas E RogersMediBeacon Inc, St. Louis, MO, USA.
Jeng Jong ShiehMediBeacon Inc, St. Louis, MO, USA.
Martin P DebreczenyMediBeacon Inc, St. Louis, MO, USA.
James R JohnsonMediBeacon Inc, St. Louis, MO, USA.
Roy B DyerImmunochemical Core Laboratory, Mayo Clinic, Rochester, MN, USA.
Ravinder J SinghImmunochemical Core Laboratory, Mayo Clinic, Rochester, MN, USA.
Phillip I TarrDepartment of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. tarr@wustl.edu.
Medibeacon (United States) · USWashington University in St. Louis · USMayo Clinic · USMayo Clinic in Arizona · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
NIDDK NIH HHS P30 DK052574
6 · The paper itself

Abstract

The healthy gut restricts macromolecular and bacterial movement across tight junctions, while increased intestinal permeability accompanies many intestinal disorders. Dual sugar absorption tests, which measure intestinal permeability in humans, present challenges. Therefore, we asked if enterally administered fluorescent tracers could ascertain mucosal integrity, because transcutaneous measurement of differentially absorbed molecules could enable specimen-free evaluation of permeability. We induced small bowel injury in rats using high- (15 mg/kg), intermediate- (10 mg/kg), and low- (5 mg/kg) dose indomethacin. Then, we compared urinary ratios of enterally administered fluorescent tracers MB-402 and MB-301 to urinary ratios of sugar tracers lactulose and rhamnose. We also tested the ability of transcutaneous sensors to measure the ratios of absorbed fluorophores. Urinary fluorophore and sugar ratios reflect gut injury in an indomethacin dose dependent manner. The fluorophores generated smooth curvilinear ratio trajectories with wide dynamic ranges. The more chaotic sugar ratios had narrower dynamic ranges. Fluorophore ratios measured through the skin distinguished indomethacin-challenged from same day control rats. Enterally administered fluorophores can identify intestinal injury in a rat model. Fluorophore ratios are measureable through the skin, obviating drawbacks of dual sugar absorption tests. Pending validation, this technology should be considered for human use.

Indexed as

AnimalsDisease Models, AnimalFluorescent DyesGastrointestinal TractIndomethacinIntestinal DiseasesIntestinal MucosaPermeabilityRatsSkinStaining and LabelingUrinalysisUrineFluorescent DyesIndomethacin

Identifiers

PMID28883476
PMCPMC5589723
OpenAlexW2753297065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.